Since inflammatory factors, such as IL1β and IL6, increase risk of cardiovascular diseases [60, 61], the signaling from ER stress to inflammation induced by the TKIs may be a potential target for treating cardiotoxicity. This evidence concerns the gene IL6 and cardiovascular disorder.